OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
August 02, 2018
Jean-Yves Balfin, product manager at Korsch AG, speaks to Pharmaceutical Technology about the ins and outs of multilayer tableting.
Frustrated by slow market adoption, Gottlieb maps out new plan for biosimilar competition.
Low-temperature chemistry enables performance of more challenging and selective chemistry.
Increasing dwell time can improve tablet production.
August 01, 2018
Determining how much containment is needed for API handling requires evaluation of multiple factors.
July 23, 2018
The acquisition will place Cambrex into the finished dosage form CDMO market.
July 19, 2018
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
July 09, 2018
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
July 02, 2018
Traditional glass and polymeric materials compete for market share in primary packaging for parenteral drug products.
The delivery device and drug form should be considered when choosing a test method for identifying and measuring particulates in inhaled drug products.